New appointment at Achillion
This article was originally published in Scrip
Achillion Pharmaceuticals, a US company focused on the discovery and development of small molecule drugs to combat infectious diseases, has named Joseph Truitt vice-president of business development and chief commercial officer. Mr Truitt has held various senior management positions during his 20-year career. Most recently, he was vice-president of business development and product strategy for Lev Pharmaceuticals.